{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:00:20Z","timestamp":1787828420736,"version":"build-2784847793"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.autrev.2006.11.005","type":"journal-article","created":{"date-parts":[[2006,12,21]],"date-time":"2006-12-21T08:05:03Z","timestamp":1166688303000},"page":"409-414","source":"Crossref","is-referenced-by-count":75,"title":["Ocular manifestations in antiphospholipid syndrome"],"prefix":"10.1016","volume":"6","author":[{"given":"Gordana","family":"Suvajac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ljudmila","family":"Stojanovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetislav","family":"Milenkovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2006.11.005_bib1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0039-6257(02)00289-8","article-title":"Primary anti-phospholipid antibody syndrome (APS)","volume":"47","author":"Durrani","year":"2002","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.autrev.2006.11.005_bib2","first-page":"486","article-title":"The anticardiolipin syndrome","volume":"13","author":"Hughes","year":"1986","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2006.11.005_bib3","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1034\/j.1600-0420.1998.760129.x","article-title":"Antiphospholipid antibodies in patient with retinal vascular occlusion","volume":"76","author":"Giordano","year":"1998","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.autrev.2006.11.005_bib4","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0002-9394(02)02078-0","article-title":"Antiphospholipid antibody syndrome in a six-year-old female patient","author":"Hartnett","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.autrev.2006.11.005_bib5","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0002-9394(00)00884-9","article-title":"Ocular features associated with anticardiolipin antibodies: descriptive study","volume":"131","author":"Miserocchi","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.autrev.2006.11.005_bib6","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.arcmed.2005.03.032","article-title":"The antiphospholipid antibody syndrome research in patients with retinal venous occlusion","volume":"36","author":"Ilhan","year":"2005","journal-title":"Arch Med Res"},{"key":"10.1016\/j.autrev.2006.11.005_bib7","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.semarthrit.2004.05.002","article-title":"Intraocular inflammation in autoimmune diseases","volume":"34","author":"Pras","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2006.11.005_bib8","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s00417-004-1022-8","article-title":"Hypopyon uveitis associated with systemic lupus erythematosus and aniphospholipid antibody syndrome","volume":"243","author":"Zink","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.autrev.2006.11.005_bib9","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1442-9071.2000.00322.x","article-title":"Bilateral choroidal infarction in a patient with antiphospholipid syndrome: a case report","volume":"28","author":"Ang","year":"2000","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.autrev.2006.11.005_bib10","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/01.icu.0000144389.97491.52","article-title":"The antiphospholipid antibody syndrome: diagnostic aspects","volume":"15","author":"Behbehani","year":"2004","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.autrev.2006.11.005_bib11","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0161-6420(95)31028-7","article-title":"Ocular vaso-occlusive disease in primary antiphospholipid syndrome","author":"Castanon","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.autrev.2006.11.005_bib12","series-title":"Clinical Ophthalmology","first-page":"122","article-title":"Keratitis in systemic collagen vascular disorders","author":"Kanski","year":"2004"},{"key":"10.1016\/j.autrev.2006.11.005_bib13","series-title":"The Sclera and Systemic Disorders","first-page":"238","author":"Hazelman","year":"1976"},{"key":"10.1016\/j.autrev.2006.11.005_bib14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1023\/A:1006305705080","article-title":"Ocular involvement in primary antiphospholipid syndrome","author":"Demirci","year":"1998","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.autrev.2006.11.005_bib15","first-page":"661","article-title":"Ophthalmic signs in antiphospholipid syndrome","volume":"106","author":"Sobecki","year":"2004","journal-title":"Klin Oczna"},{"key":"10.1016\/j.autrev.2006.11.005_bib16","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0181-5512(05)81087-3","article-title":"Bilateral retinal vascular occlusion during antiphospholipid antibody syndrome: a case report","volume":"28","author":"Trojet","year":"2005","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.autrev.2006.11.005_bib17","first-page":"31","article-title":"Retinal vascular lesions in systemic lupus erythematosus and secondary antiphospholipid syndrome","volume":"121","author":"Ermakova","year":"2005","journal-title":"Vestn Oftalmol"},{"key":"10.1016\/j.autrev.2006.11.005_bib18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1442-9071.2004.00766.x","article-title":"Review of severe vaso-occlusive retinopathy in systemic lupus erythematosus and the antiphospholipid syndrome: associations, visual outcomes, complications and treatment","volume":"32","author":"Au","year":"2004","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.autrev.2006.11.005_bib19","series-title":"Clinical Ophthalmology","first-page":"479","article-title":"Retinal vein occlusion","author":"Kansky","year":"2004"},{"key":"10.1016\/j.autrev.2006.11.005_bib20","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1001\/archopht.1994.01090180088041","article-title":"Antiphospholipid antibodies in retinal vascular occlusions","volume":"112","author":"Glaced-Bernard","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.autrev.2006.11.005_bib21","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0002-9394(99)00311-6","article-title":"Antiphospholipid antibodies and retinal thrombosis in patients without risk factors: a prospective case-control study","volume":"128","author":"Cobo-Soriano","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.autrev.2006.11.005_bib22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0049-3848(96)00119-3","article-title":"Antiphospholipid-protein antibodies are not an uncommon feature in retinal venous occlusions","volume":"83","author":"Coniglio","year":"1996","journal-title":"Thromb Res"},{"key":"10.1016\/j.autrev.2006.11.005_bib23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0002-9394(99)00278-0","article-title":"Multiple retinal arteriolar occlusions associated with coexisting primary antiphospholipid syndrome and factor V Leiden mutation","author":"Dori","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.autrev.2006.11.005_bib24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0002-9394(00)00873-4","article-title":"Reversal of non arteritic anterior ischemic optic neuropathy associated with coexisting primary antiphospholipid syndrome and factor V Leiden mutation","volume":"131","author":"Srinivasan","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.autrev.2006.11.005_bib25","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s100670050069","article-title":"Optic neuropathy in systemic lupus erythematosus and antiphospholipid syndrome (APS): clinical features, pathogenesis, review of the literature and proposed ophthalmologic criteria for APS diagnosis","volume":"8","author":"Giorgi","year":"1999","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2006.11.005_bib26","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/00041327-200112000-00006","article-title":"Catastrophic antiphospholipid antibody syndrome manifesting as an orbital ischemic syndrome","volume":"21","author":"Vaphiades","year":"2001","journal-title":"Neuro-ophtalmology"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997206002138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997206002138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T11:54:35Z","timestamp":1547121275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997206002138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S1568997206002138"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2006.11.005","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}